The influence of residual apixaban on bleeding complications during and after catheter ablation of atrial fibrillation
Background: The periprocedural protocol for atrial fibrillation (AF) ablation commonly includes anticoagulation therapy. Apixaban, a direct oral anticoagulant, is currently approved for clinical use; however, little is known about the effects of residual apixaban concentration on bleeding complicati...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-10-01
|
Series: | Journal of Arrhythmia |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1880427617301230 |